Closed-loop system– tag –
-
Five Key Trends in Diabetes Technology for 2026: Longer-Lasting CGMs, OTC Expansion, and Multi-Biomarker Monitoring Lead Innovation
DiabeticSupplieInc.com Unknown Overview Five major trends are shaping diabetes technology in 2026, including longer-lasting continuous glucose monitoring (CGM) sensors like the FDA-cleared Dexcom G7 15-day system, expanded CGM access for... -
Abbott’s Libre Duo 10 Day System Receives FDA De Novo Clearance as First Integrated Continuous Glucose-Ketone Monitor
Pharmacy Times USA Overview Abbott's Libre Duo 10 Day system has received FDA De Novo clearance, becoming the first integrated continuous glucose-ketone monitoring (iCGK) system in the U.S. and the world's first wearable device to track ... -
UC San Diego’s Microneedle ‘Under-Skin Lab’ Continuously Monitors Lactate and Levodopa, Paving Way for Closed-Loop Drug Delivery in Parkinson’s Disease
UC San Diego Today USA Overview Researchers at UC San Diego are developing a 'lab under the skin' using microneedle technology, capable of continuous, real-time sensing of biomarkers and drugs like lactate and levodopa in interstitial fl... -
UCSB Professor Plaxco Develops In-Vivo Biosensor for Reliable, Continuous 1-Week Monitoring of Antibiotic Tobramycin
UCSB Engineering USA Overview Professor Kevin Plaxco's team at UC Santa Barbara has developed a biosensor capable of reliably and continuously measuring antibiotic tobramycin levels in the body for up to one week. Housed in a 3D-printed ... -
Rising Costs of CGM and Insulin Pumps Threaten Patient Access to Home Medical Equipment in Diabetes Care: AAHomecare Warns
AAHomecare (via Facebook) America Overview Reports indicate that increasing costs for Continuous Glucose Monitoring (CGM) and insulin pumps are impacting access to diabetes care and home medical equipment. Due to largely stagnant reimbur... -
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
UnitedHealthcare Updates CGM and Insulin Delivery Coverage Policy: Non-Invasive CGMs Excluded Due to Lack of Evidence
UHC Provider Portal (UnitedHealthcare) USA Overview UnitedHealthcare (UHC) has updated its medical policy regarding coverage for continuous glucose monitoring (CGM) and insulin delivery systems for diabetes management. The updated policy... -
Nature Sensors Review Highlights AI-Powered Closed-Loop Wearable Bioelectronics: Charting a Course for Personalized, Autonomous Healthcare
Facebook (Nature Portfolio) UK Overview A Nature Sensors review article details how AI-powered closed-loop wearable bioelectronics promise to usher in a new era of personalized, autonomous healthcare by integrating real-time biosensing w... -
Medtronic Simplifies Diabetes Management with Integrated MiniMed 780G and Simplera Sync™ Sensor
Southeast Diabetes Inc. USA Overview Medtronic has introduced a state-of-the-art diabetes management solution, pairing its MiniMed 780G insulin pump system with the Simplera Sync™ sensor. Simplera Sync™ is an all-in-one, disposable conti... -
AI-Native Biosensors Fuel Precision Drug Delivery: Trinity Biotech and Latch Medical Target Diabetes, Obesity
GlobeNewswire (Trinity Biotech) Ireland Overview Trinity Biotech and Latch Medical have formed a strategic partnership to revolutionize diabetes and obesity treatment. The collaboration integrates Trinity Biotech's AI-native CGM+ wearabl...
12